Koaburaside is primarily studied for its potential anti-cancer properties, particularly in the inhibition of tumor cell proliferation. It has shown activity against certain types of leukemia and solid tumors by inducing apoptosis and cell cycle arrest. The compound also exhibits anti-inflammatory effects, making it a candidate for research in inflammatory diseases. Additionally, koaburaside has been investigated for its immunomodulatory actions, where it may enhance the body’s immune response against malignant cells. Due to its natural origin and bioactive profile, it serves as a lead compound in the development of novel chemotherapeutic agents.